/80 mm Hg rather than 140/90 mm Hg is considered elevated arterial blood pressure, and approximately, half of the United States adult population meet this criteria. 1 As the United States population ages, the number of patients diagnosed with hypertension will continue to increase. The 2017 guideline reflects the recognition that arterial blood pressure measurements thought to be prehypertensive, correlate with pathophysiological changes in the cardiovascular system, and increase a patient's risk for hypertension-associated comorbidities, including stroke and death. This new guideline highlights the importance of early identification and increased patient monitoring to prevent hypertension-related side effects.
anticoagulatory factors that hyperpolarize the underlying vascular smooth muscle to maintain appropriate blood flow. In hypertension, there is a shift in the balance of these factors. Generally, the endothelium from both hypertensive animals and patients increases its secretion of procontractile factors and decreases its secretion of prorelaxant factors. However, there are instances where vasodilatory factors are elevated in hypertension, 4 likely as a compensatory mechanism during the development phase of high blood pressure. It has also been acknowledged that endothelium-derived hyperpolarization could occur through intercellular coupling and therefore be considered a solely electrical event. There is ongoing discovery of novel vasoactive molecules that are secreted from the endothelium and directly impact vascular tone or indirectly modulate the abundance of traditional vasoactive molecules (e.g., nitric oxide bioavailability, prostaglandin synthesis). Damage-associated molecular patterns, cell components released or secreted during cell death, have emerged as novel mediators 5 and modulators 6 of endothelial function, acting in an autocrine, paracrine, and endocrine fashion. Abbreviations: DAMP, damage-associated molecular pattern; EDHF, endothelium-derived hyperpolarizing factor; IL, interleukin; NO, nitric oxide; PVAT, perivascular adipose tissue; TGF, transforming growth factor; TNF, tumor necrosis factor; VSMC, vascular smooth muscle cell; ?, unknown effect.
Endothelial cells are linked to one another via junctional structures forming a barrier. In hypertension, this barrier function is impaired, and the permeability of the endothelium increases. Endothelium dysfunction diminishes the protection of end organs and allows for increased passage of solutes and immune cells from the bloodstream, causing increased edema and inflammation. 7 Prohypertensive factors contribute to endothelial barrier dysfunction. For example, angiotensin-II (Ang-II) disrupts the blood-brain barrier in spontaneously hypertensive rats (SHR), 8 and aldosterone can diminish endothelial nitric oxide synthase activity via rearrangement of the actin cytoskeleton. 9 Furthermore, as RhoA is generally considered the master regulator of actin cytoskeleton formation, 10 an improvement in endothelial barrier function could be another mechanism of how RhoA/ROCK inhibition (e.g., fasudil) acts as an antihypertensive therapy. 11 Similar to vasoactive molecules, novel mediators of endothelial permeability and actin cytoskeleton dynamics are emerging. 12, 13 Whether these novel factors contribute to the pathogenesis of hypertension is currently an unexplored area of research.
Finally, the endothelium can also function as a metabolic unit, with a host of proteolytic enzymes and transporters that take up and process circulating molecules. The endothelium can clear prohypertensive molecules such as lowdensity lipoprotein, 14 prostaglandins, 15 and endothelin-1. 16 In hypertension, however, the metabolism of endothelial cells becomes dysfunctional promoting a procontractile, proinflammatory, and pro-oxidative milieu. For example, uptake of the above mentioned prohypertensive molecules, as well as their destruction into inactive metabolites (e.g., serotonin) is impaired. 17, 18 In summary, it is well established that the secretory, barrier, and metabolic function of the endothelium becomes ineffective at maintaining the necessary degree of vascular homeostasis, and this promotes the development and maintenance of hypertension. However, still being revealed are multiple and intertwining mechanisms underlying the endothelium dysfunction, beyond high blood pressure itself, as well as the multiple ways that the endothelium can exert autocrine, paracrine, and endocrine influences on itself and the other organs involved in the etiology of hypertension.
Interstitial cells of Cajal
The interstitial cells of Cajal are a subpopulation of cells found in tissues containing smooth muscle. They are irregular in shape, contain thin processes, and are noncontractile. 19 The presence and function of interstitial cells within the vasculature have not been greatly characterized. The location of these cells varies depending on tissue type, ranging from the subendothelial layer to the media-adventitia border of veins (portal, pulmonary, postcaval) and arteries (mesenteric, cerebral, aortic, carotid). [20] [21] [22] [23] [24] [25] [26] Interstitial cells of Cajal exhibit pacemaker activity within veins, whereas their function in arteries is less clear. Some evidence suggests these cells have roles in angiogenesis, intercellular communication, and vessel maintenance. 27 Knowledge on the role of vascular interstitial cells of Cajal in hypertension is greatly lacking, which may be a consequence of the inconsistency in nomenclature and/ or lack of biomarkers. However, one study demonstrated that hypertension induced partial loss and rupture of these cells, and this was associated with a disturbance in intestinal smooth muscle cell contraction. 28 Therefore, it is reasonable to hypothesize that functional and structural changes within the vascular interstitial cells of Cajal may play a role in the development and/or maintenance of hypertension.
TUNICA MEDIA

Vascular smooth muscle cells
Total peripheral resistance is defined by Poiseuille's law, in which 3 factors are the primary determinants of the resistance to blood flow within a vessel: lumen diameter, vessel length, and viscosity of the blood. The most significant is the lumen diameter, given that vessel resistance is inversely proportional to the radius to the fourth power (r 4 ). Therefore, a 50% reduction in radius should increase resistance 16-fold. Adjustments in total peripheral resistance are directly determined by alterations in the morphology and/or function of VSMCs. Under physiological conditions, VSMCs are embedded in a network of elastin-rich extracellular matrix and the basement membrane, which surrounds each VSMCs and separates the VSMCs-containing medial cell layer from the endothelium. 29 The basement membrane acts as a barrier to VSMCs migration, proliferation, and hypertrophy.
VSMCs structural changes in hypertension are collectively termed vascular remodeling. It is observed when there is a change in diameter of a fully relaxed vessel that is not explained by a change in transmural pressure or compliance and thus is structural in nature. 30 Vascular remodeling is classified as hypertrophic, eutrophic, or hypotrophic. Furthermore, remodeling can be inward (reduced luminal diameter) (Figure 1 ) or outward (increased luminal diameter). 31, 32 In hypertension, increased peripheral resistance associated to structural changes (remodeling) of the vasculature was proposed in the 1950s by Folkow. 33 The most common type in hypertension is inward remodeling, causing a reduction of the luminal diameter under passive conditions. Outward remodeling is generally seen during antihypertensive treatment and in conditions of increased flow. 31 In inward eutrophic remodeling, wall cross-sectional area will be preserved by repositioning of the VSMCs, which normalizes the circumferential stress of the resistance vessel exposed to increased blood pressure. It is suggested that the inward eutrophic remodeling precedes and prevents hypertrophy if the rearrangement effectively normalizes the circumferential stress. However, if the rearrangement does not occur, VSMCs are stimulated and the cross-sectional area is injured. 34 These structural changes increase the wall-to-lumen ratio which causes an increase in the peripheral resistance.
Consistent findings demonstrate that during hypertension, VSMCs hyperplasia and hypertrophy represents 2 of the crucial anomalies responsible for the vascular inward remodeling and subsequent development of increased total peripheral resistance. 30 Interestingly, the exaggerated response of VSMCs to growth factors in SHR persists in cell culture, indicating an intrinsic defect in hypertension-associated VSMCs hyperplasia and hypertrophy. 35 For instance, many of the same factors that induce experimental hypertension also induce hypertrophy and hyperplasia in VSMCs, such as Ang-II, norepinephrine, and mineralocorticoids. 30 Recent evidence has revealed that actin polymerization in VSMCs contributes to vascular remodeling. Accordingly, it has been observed that pressure-induced actin polymerization in VSMCs is one mechanism underlying myogenic behavior. 36 Additionally, prolonged vasoconstriction of resistance arteries also involves VSMCs actin polymerization. 37 For both the mechanotransduction pathway and agonist-induced changes in actin polymerization, RhoA-CdC42 pathway has been shown to be a primary contributor. 38 Functionally, Ca 2+ plays a central role of in the physiology and pathophysiology of VSMCs contractility. An increase in intracellular Ca 2+ concentration is essential for activation of myosin light-chain kinase (MLCK), phosphorylation of MLC, myofilament cross-bridge cycling, and contraction. For instance, Ca 2+ handling changes were found in human and experimental models of hypertension, including upregulation of receptor-operated and/or store-operated Ca 2+ channels expression, upregulation or downregulation of L-type Ca 2+ channels, increase in Ca 2+ sensitization via RhoA activation, and increased mitochondria and sarcoplasmic reticulum Ca 2+ stores. 30 Therefore, disturbances in the handling of Ca 2+ may be the most important factor unifying different mechanisms of VSMC dysfunctions in hypertension.
Fibrocytes
First described by Dr Bucala's group in 1994 as a new leukocyte subpopulation exhibiting fibroblast-related properties, fibrocytes are considered one of the first cell lines physiologically responsible for wound repair and tissue regeneration. 39, 40 Fibrocytes are bone marrow-derived mesenchymal progenitor cells that express stem cell (CD34), pan-hematopoietic (CD45), and monocyte markers (CD14 and 11) on their surface. 40 Fibrocytes synthesize and release cytokines, metalloproteinases, and components of the connective tissue matrix (type I and III collagen, vimentin, and fibronectin), all of which contribute to tissue repair. 41 The ability of fibrocytes to differentiate into fibroblasts or myofibroblasts, both responsible for collagen and proteoglycan production, further contributes to the tissue repair process. 42 In physiological conditions, fibrocytes are not abundantly present in the arterial wall. However, in pathologic states, such as in hypertension, 43, 44 fibrocytes are recruited from the circulation through chemotactic ligand-receptor interactions to the injured tissue. During hypertension, resident fibrocyte hypertrophy and hyperplasia have also been described. 45, 46 Collagen accumulation and extracellular matrix reorganization, affected by resident fibrocytes, are also important factors that contribute to vessel wall stiffness and hypertension. 43 In an experimental study of Ang-II-induced hypertension rodent model, fibrocytes played a pivotal role in the generation of vascular fibrosis through an increase in type I collagen production. 44 Also, in pudendal arteries from SHR, an increase in fibrocyte markers was related to vascular dysfunction and erectile dysfunction. 47 However, it is still controversial if circulating or resident fibrocytes play a major role in hypertension. For instance, little is known about how vascular resident fibrocytes contribute to the initial process of vascular remodeling. Furthermore, the suppressive effect of certain proinflammatory cytokines on fibrocyte formation and the role of this regulation in the development of vascular dysfunction is still not understood.
TUNICA EXTERNA Fibroblasts
Fibroblasts are the most abundant cell type within the tunica externa and key regulators of vascular wall structure and function. 48 In vessels from normotensive rats, fibroblasts have a fusiform or polygonal morphology and have structural, secretory, and communicative (i.e., cell-to-cell interaction control) functions. Fibroblasts secrete growth factors, chemokines, and cytokines, which help control vascular function, 49 elements of the extracellular matrix and aid in the degradation of extracellular matrix components.
Fibroblasts are considered the principal cells for vascular remodeling in response to injury. 50 However, during hypertension, fibroblasts undergo a morphological change that is accompanied with proliferation and migration into the tunica media. 51 This response to injury also leads to the generation of chemokines, cytokines, adhesion molecules, reactive oxygen species, and matrix metalloproteinases (Table 1) , along with proliferation of the vasa vasorum, eventually resulting in irreversible functional and structural remodeling of the vessel wall. 48
Pericytes
Pericytes are described as perivascular cells that "wrap" around arterioles, precapillary arterioles, capillaries, postcapillary venules, and venules 52 ( Figure 2) . The ratio of pericytes to endothelial cells varies depending on which organ they are located in. Pericytes are found in greater numbers in areas of tight endothelial barrier regulation and slow endothelial proliferation. These cells exhibit a variety of roles that include scaffolding, communication, mechanical contractile force transmission, anchoring sites, and both the inability and ability to regulate vascular diameter in capillaries. 53 Current literature suggests that not all pericytes are the same, as they exhibit different morphology and function; cell shape may range from a flat to a round cell body, and cell processes range from (i) wrapping entirely around a vessel, (ii) laying unidirectional in parallel with the length of the vessel, and (iii) exhibiting short processes creating a satellitelike cell shape. 52 These differences can be categorized into 3 subclasses based on pericytes location along the capillary bed. 52, 54 Pericytes found closer to arterioles tend to exhibit circumferential processes that wrap around vessels. 52, 54 These pericytes have been reported to have more alphasmooth muscle actin expression and have the ability to contract. 52 Pericytes found around capillary beds tend to exhibit processes that run parallel to the vessel and express less alpha-smooth muscle actin than the pericytes found closer to arterioles. Pericytes found closer to venules have more of a satellite cell shape and do not express alpha-smooth muscle actin; therefore, they do not contract. [54] [55] [56] [57] [58] The loose definition of pericytes and the contradictory role of this class of cells may account for varying reports of pericytes being both contractile and noncontractile. 54, 58, 59 Hypertension has been associated with both an increase and a decrease in pericyte numbers. [60] [61] [62] [63] [64] In mice with Ang-II-induced hypertension, the number of pericytes in cerebral arteries is decreased, leading to blood-brain barrier disruption. 60 In contrast, SHR show increased pericyte number within the brain microcirculation, specifically within the motor cortex and pons. 61 In pulmonary arterial hypertension, pulmonary arteries from both human and mice exhibit an increased number of pericytes with associated fibrosis and membrane thickening, and these where found to contribute to endothelial dysfunction. [62] [63] [64] This phenomenon was suggested to be location specific and occur in response to recruitment signals to stabilize vessels.
PERIVASCULAR ADIPOSE TISSUE
In 1991, Cassis and Soltis 65 used rat aorta from male Sprague-Dawley with and without PVAT to measure isometric force. Norepinephrine-induced contraction was reduced in tissues with PVAT. This experiment provided the first evidence that PVAT could change the function of the vessel around which it resided and possessed vasoactive functions. Since the publication of this seminal paper, scientists have discovered the importance of PVAT in modifying vessel function in multiple species, including humans, and in multiple vessel types, from large-sized vessels (aorta) to resistance-sized vessels. A majority of the work, however, has been done in larger size vessels such as the thoracic aorta because for these vessels, PVAT is easily identified. Current work has been reviewed by multiple investigators, and we encourage you to read these important reviews. [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] PVAT is composed of multiple different cell types and tissues, including adipocytes, different cell types in the stromal vascular fraction, including small vasculature that supplies cells within PVAT with nutrients, fibroblasts and immune cells, and potentially nerves that innervate PVAT. Adipocytes can be both brown and white, and all arteries do not have the same "type" of PVAT. In fact, in the rat, the thoracic aorta is brown fat, the superior mesenteric artery is a mix of brown and white, and PVAT around the small mesenteric resistance arteries and veins is white. As such, no finding on a particular PVAT is necessarily applicable to another PVAT. Because there is no barrier between PVAT and the vessel, communication (crosstalk) can occur between PVAT and the vessel it surrounds.
The PVAT anticontractile effects are caused by the release of different factors, including adiponectin, hydrogen sulfide, nitric oxide, etc. 75 PVAT also has procontractile effects, caused by the production of vasoactive, contractile adipokines (such as angiotensin-II), and other small molecules (Table 1) . 76 Thus, it is the balance of molecules released from PVAT, as well as the bidirectional cross-talk, 77 that ultimately determines the overall contributions made by PVAT to vessel contractility. The PVAT anticontractile action is lost in hypertension. 68, 69 The forms in which this anticontractile nature has been lost include both genetic and experimental models, as well as in humans with essential hypertension, though more work has been in done in animal models of obesity because of the increased burden of fat.
Immune cell infiltration and PVAT
PVAT appears to be a harbor for immune cells, both in healthy and pathologic states. This idea was led by the work of Tomas Guzik, who discovered that the presence of T cells was essential to the development of Ang-II-induced hypertension and hypertension-associated vascular dysfunction. 78 Additionally, atheroprotective IgM-producing B cells were observed in the aortic PVAT of mice. 79 Eosinophils may also be key in regulating the normal PVAT anticontractile function, 80 and follicular dendritic cells emerge from precursors that exist in the perivascular space. 81 Just recently, the importance of T cells in hypertension, as recruited to the PVAT, in both Ang-II and DOCA-salt hypertension in mice, was called into question with the inability of multiple labs across the country to reproduce the previously observed protection of the Rag1 mice (lack T and B cells) from Ang-II-induced hypertension. 82 In dysfunctional PVAT (e.g., hypertension), immune cell infiltration becomes more prominent. Infiltrating cells include macrophages, memory T cells, IL-10-producing FoxP3 + T regulatory cells, natural killer cells, and granulocytes. 83 Immune cell infiltrates in the PVAT contribute to the low-grade inflammation seen in multiple cardiovascular diseases. [84] [85] [86] [87] For instance, in humans, an increased burden of aortic PVAT in cardiovascular disease was seen in the Framingham Heart Study. 88 Unfortunately, no PVAT-specific markers have been found that would permit PVAT-specific interventions. It would be ideal to have a biomarker or agent that could potentially turn a "sick" PVAT into a "healthy" PVAT.
HYPERTENSION-RELATED CHANGES IN SPECIAL CIRCULATIONS
Renal circulation
The role that the kidney plays in the development and maintenance of hypertension has been described for centuries. 89 The introduction of the pressure-natriuresis hypothesis by Arthur Guyton et al. 90 in the 1970s suggested that a modification to the kidney's capacity for water and sodium excretion was required for the perpetuation of chronic elevation of intra-arterial pressure, whereby the equilibrium point for salt and water excretion was shifted to a higher blood pressure. While this remains a largely accepted notion, some controversy arises with studies suggesting independent control of blood pressure by predominately neural and vascular mechanisms. [91] [92] [93] The far reaching and complex role of renal physiology in blood pressure regulation is outside of the scope of this mini-review. However, hypertension is also recognized as one of the most important causes of end-stage renal disease, 94 and the pathogenesis of hypertensive renal disease remains an area of great research interest and debate.
Kidney damage is a prominent feature in most experimental models of hypertension. [95] [96] [97] Many of the structural and functional changes in the vasculature recognized as hallmarks of chronic hypertension have also been observed in the kidney and warrant special consideration as components of this pathogenesis remain unclear. Specifically, renal injury in hypertension is heterogeneously distributed to the juxtamedullary region and outer medulla as has been observed in SHR, Dahl salt-sensitive hypertensive rats, renovascular hypertension, and Ang-II-induced hypertension. [98] [99] [100] [101] This results from the greater pressure gradient across the afferent arteriole in the juxtamedullary region, adjacent to the large arcuate artery, in contrast to the gradual pressure reduction that occurs over the length of the vasculature in the superficial cortical regions, including the entire interlobular artery and its afferent arterioles. 98 A landmark study by Mori et al. 101 supports the concept that elevated arterial pressure itself is primarily responsible for this renal injury. Mori et al. used the servocontrol method to maintain normotensive perfusion pressure to 1 kidney while inducing systemic hypertension via Ang-II infusion and showed extensive juxtamedullary, glomerular, and outer medullary tubulointerstitial injury in the pressure-uncontrolled kidney; this was largely prevented in the pressure-controlled contralateral kidney despite exposure to high levels of Ang-II.
The exact temporal and spatial relationships between vascular, glomerular, and tubular changes in hypertensive renal disease remain unclear. Afferent arteriolar wall hypertrophy and glomerular capillary collapse have been observed and correlated with reduced glomerular and tubular flow in SHR, suggesting a causal relationship between afferent arteriolopathy and tubular injury. 102 Thickening of the interlobular artery has been shown with infiltration of lymphocytes, VSMC proliferation, and imbalance of collagen metabolism featuring increased synthesis and inhibition of breakdown leading to fibrosis. 95, 103 Changes in vascular function and morphology precede renal damage in SHR, further indicating their importance in the pathogenesis of hypertensive renal disease. 99, 104, 105 Whether vascular dysfunction is present in the renal vasculature prior to observable morphologic changes is poorly understood. Both angiotensin receptor blockers and calcium channel blockers have been shown to reduce glomerular sclerosis and arteriolar wall thickening in experimental animals; however, if this is due to mechanisms beyond their blood pressure-lowering effects remains unclear. [106] [107] [108] It is well established that chronic activation of the innate immune system contributes to both hypertension and kidney injury. Work in our laboratory has shown increased circulation of mitochondrial DNA in SHR 6 with associated systemic inflammation and vascular dysfunction via formyl peptide receptor activation. These findings were reproduced in isolated intrarenal arteries of normotensive rats exposed to mitochondrial fragments and were not attenuated with thiazide diuretic treatment despite lowering blood pressure (unpublished data). The effects of inflammation and chronic immune system activation on the development of renal dysfunction in hypertension-associated dysfunction remain largely unclear and represent an exciting avenue for future study.
Cerebral circulation
Hypertension has devastating effects on the brain. It is the leading cause of stroke and a major cause of dementia and cognitive impairment. The cerebral vasculature has several important structural and functional differences from the peripheral circulation, which serve to maintain continuous perfusion. Surface pial arteries form an effective collateral network, and occlusion of a single vessel does not significantly reduce cerebral blood flow. However, downstream-penetrating and parenchymal arterioles are largely unbranched, and a single-vessel occlusion can significantly reduce blood flow and result in ischemia. 109 Table 2 summarizes several important structural and functional changes in cerebral arteries during hypertension.
The effects of hypertension on the cerebral circulation are numerous and complex and have been reviewed extensively elsewhere. 110, 111 The deleterious effects of hypertension in the brain include vessel rarefaction, artery remodeling, and hypertrophy, changes in vascular myogenic reactivity, and All capillaries perfused at all times Loss associated with chronic hypoperfusion and increased risk of cognitive impairment and dementia in hypertension Abbreviation: ACEI, angiotensin converting enzyme inhibitors; SHR, spontaneously hypertensive rats. endothelial dysfunction with compromise of the bloodbrain barrier. Numerous cell types play a unique role in the cerebral circulation, and their role in hypertension is summarized in Table 3 .
Hepatic circulation
The liver receives one-third of its blood supply from the hepatic artery and the remaining two-thirds from the portal vein. Its immense vascularization is highlighted by the fact that it receives 25% of cardiac output despite only comprising 2% of body weight. This is accomplished by a pressure gradient of only a few millimeters of mercury. Due to extremely distensible capacitance and venous resistance sites, the liver plays a crucial role in response to decreased or increased blood volume and has a recognized role in determining the response to vasopressors, antihypertensives, and afterload-reducing agents. 112 Essential hypertension is strongly linked to the development of nonalcoholic fatty liver disease. 113 Both, nonalcoholic fatty liver disease and hypertension are well-established components of metabolic syndrome, and their relationship appears to be related to increased insulin resistance and total body weight. 114 Hypertension is also associated with nonalcoholic fatty liver disease independent of body mass, highlighting the importance of evaluating hypertensive patients for the development of liver disease and vice versa. 115 Interestingly, patients with hypertension are likely to become normotensive as cirrhosis develops, and hypertension is rarely manifested in patients with established cirrhosis. 116 This is likely due to an overall vasodilatory state in cirrhosis mediated through complex, interconnected mechanisms including adrenomedullin, calcitonin gene-related peptide, nitric oxide, and other vasodilators present in the splanchnic vascular bed. 116 The above observations highlight the complex role of the hepatic circulation in altering systemic hemodynamics in both the healthy and pathologic states.
CONCLUSION
Vascular dysfunction is undoubtedly associated with the genesis and/or maintenance of hypertension. Although endothelial cells and VSMCs dysfunction are the most commonly associated culprit for the vascular changes seen in hypertension, evidence shows that other cell types within the vasculature are also involved in this phenomenon (summarized in Figure 3a,b) . Unfortunately, specific markers and/or pharmacological agents that are able to differentiate cells for specific interventions are limited or simply do not exist. It is of critical importance to understand the basic physiologic role of each cell type within the vasculature and identify their contributions to the development of vascular dysfunction in hopes that new targeted therapies can be produced.
